GlycoMimetics Reports Top-line Results From Pfizer's Phase 3 Clinical Trial Evaluating Rivipansel in Sickle Cell Disease

Stock Information for GlycoMimetics Inc.

Loading

Please wait while we load your information from QuoteMedia.